CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics

As part of our inaugural CEO series, we're excited to welcome Sherine Chan, the CEO and Co-Founder of Neuroene Therapeutics.In this episode, Sherine shares her journey from academia to helming a cutting-edge biotech company. She explores the groundbreaking work her company is pioneering in targeting the powerhouses of cells: mitochondria. Sherine also dives into the influence of the Inflation Reduction Act on the development of small-molecule drugsWe also discuss: Neuroene Therapeutics' ongoing projects.The critical role of mitochondrial dysfunction in neurological conditions such as epilepsy, Parkinson's, and mitochondrial disorders.Sherine's insights for aspiring entrepreneurs and scientists.